Summary: IDSA has developed evidence-based guidelines to support clinicians and other health-care professionals in their decisions about the treatment and management of patients with COVID-19. In this document, readers can find information on the results of studies and rationale for each recommendation, clinical experience, and references to additional sources. Therapies covered include hydroxychloroquine +/- azithromycin, lopinavir/ritonavir, corticosteroids, tocilizumab, and convalescent plasma.
Information current as of 4/11/2020
Organization: Infectious Diseases Society of America
Title: Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
Web Link: Read more here!